| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1200/JCO.2002.11.004 |
| P698 | PubMed publication ID | 12011138 |
| P2093 | author name string | Russel J Reiter | |
| Charles R Thomas | |||
| Terence S Herman | |||
| Vijayalaxmi | |||
| P2860 | cites work | A human cell line from a pleural effusion derived from a breast carcinoma | Q34207627 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | melatonin | Q180912 |
| P304 | page(s) | 2575-2601 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Melatonin: from basic research to cancer treatment clinics | |
| P478 | volume | 20 |
| Q22306143 | A Radiobiological Review on Melatonin: A Novel Radioprotector |
| Q41201476 | A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers. |
| Q48207291 | Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases |
| Q26774897 | Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results |
| Q46566149 | Antioxidant activity of melatonin and a pinoline derivative on linoleate model system. |
| Q50470438 | Antioxidant effect of immediate- versus sustained-release melatonin in type 2 diabetes mellitus and healthy controls. |
| Q40405145 | Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects. |
| Q37856990 | Application of LC and LC-MS to the analysis of melatonin and serotonin in edible plants |
| Q48479439 | Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls |
| Q40376028 | Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1. |
| Q93165020 | Blue Light Deprivation Produces Depression-Like Responses in Mongolian Gerbils |
| Q37328594 | Cancer Incidence in Physicians: A Taiwan National Population-based Cohort Study. |
| Q48220091 | Chronic melatonin administration mitigates behavioral dysfunction induced by γ-irradiation |
| Q37328085 | Circulating melatonin and the risk of breast and endometrial cancer in women. |
| Q44428127 | Determination of melatonin in human plasma with solid-phase extraction, high-performance liquid chromatography and fluorescence detection |
| Q37348377 | Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts |
| Q90446356 | Different Effects of Melatonin on X-Rays-Irradiated Cancer Cells in a Dose-Dependent Manner |
| Q43215777 | Effect of melatonin on N-nitrosodiethylamine-induced hepatocarcinogenesis in rats with reference to biochemical circadian rhythms |
| Q47776084 | Effects of Caffeic Acid and Quercetin on In Vitro Permeability, Metabolism and In Vivo Pharmacokinetics of Melatonin in Rats: Potential for Herb-Drug Interaction |
| Q48919903 | Effects of chronic jet lag on the central and peripheral circadian clocks in CBA/N mice |
| Q37031603 | Epigenetic regulation: a new research area for melatonin? |
| Q35683400 | Evaluation of the antioxidant effects of melatonin on the larynx mucosa of rats exposed to environmental tobacco smoke. |
| Q37591161 | First-morning urinary melatonin and breast cancer risk in the Guernsey Study |
| Q44489311 | Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial |
| Q39985982 | Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma. |
| Q28302285 | G-protein coupled receptor expression patterns delineate medulloblastoma subgroups |
| Q58396534 | How Shift Work and a Destabilized Circadian System may Increase Risk for Development of Cancer and Type 2 Diabetes |
| Q42072113 | Hydrogels containing redispersible spray-dried melatonin-loaded nanocapsules: a formulation for transdermal-controlled delivery. |
| Q35217008 | Interactions between environmental factors and melatonin receptor type 1A polymorphism in relation to oral cancer susceptibility and clinicopathologic development |
| Q39472810 | Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells |
| Q40084736 | Involvement of protein kinase C in melatonin's oncostatic effect in C6 glioma cells. |
| Q48930736 | Light at night and melatonin have opposite effects on breast cancer tumors in mice assessed by growth rates and global DNA methylation |
| Q43241340 | Light intensity exposure, sleep duration, physical activity, and biomarkers of melatonin among rotating shift nurses |
| Q79280587 | Light, timing of biological rhythms, and chronodisruption in man |
| Q47140063 | Long-Term Sleep Duration as a Risk Factor for Breast Cancer: Evidence from a Systematic Review and Dose-Response Meta-Analysis |
| Q38070351 | Management of anxiety and sleep disorders: role of complementary and alternative medicine and challenges of integration with conventional orthodox care. |
| Q38093018 | Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells |
| Q59133781 | Melatonin Can Strengthen the Effect of Retinoic Acid in HL-60 Cells |
| Q60912712 | Melatonin May Increase Anticancer Potential of Pleiotropic Drugs |
| Q92749740 | Melatonin Regulates Breast Cancer Progression by the lnc010561/miR-30/FKBP3 Axis |
| Q34994700 | Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives. |
| Q24645648 | Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? |
| Q64053319 | Melatonin and non-small cell lung cancer: new insights into signaling pathways |
| Q34796036 | Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research |
| Q99565353 | Melatonin and urological cancers: a new therapeutic approach |
| Q39172224 | Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1α. |
| Q34647628 | Melatonin anticancer effects: review |
| Q33397763 | Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials |
| Q52881857 | Melatonin attenuates 60 Co γ-ray-induced hematopoietic, immunological and gastrointestinal injuries in C57BL/6 male mice. |
| Q37164560 | Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells |
| Q58454430 | Melatonin directly interacts with cholesterol and alleviates cholesterol effects in dipalmitoylphosphatidylcholine monolayers |
| Q37465949 | Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway |
| Q33889427 | Melatonin for the prevention and treatment of cancer |
| Q61809393 | Melatonin for the treatment of gastroesophageal reflux disease; protocol for a systematic review and meta-analysis |
| Q37686540 | Melatonin improves spermatogonial stem cells transplantation efficiency in azoospermic mice |
| Q46641268 | Melatonin inhibits cholangiocarcinoma and reduces liver injury in Opisthorchis viverrini-infected and N-nitrosodimethylamine-treated hamsters |
| Q36551143 | Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells |
| Q53358016 | Melatonin reduces X-ray radiation-induced lung injury in mice by modulating oxidative stress and cytokine expression. |
| Q61450088 | Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1α/ROS/VEGF |
| Q39290492 | Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model |
| Q33624824 | Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis |
| Q45278249 | Melatonin-induced modulation of glucose metabolism in primary cultures of rabbit kidney-cortex tubules |
| Q38265922 | Melatonin: a "Higgs boson" in human reproduction |
| Q37755679 | Melatonin: a multitasking molecule |
| Q36984675 | Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes |
| Q44746304 | Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients |
| Q92011855 | Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma |
| Q38137168 | Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review |
| Q35037632 | New antioxidant drugs for neonatal brain injury. |
| Q34202626 | Night-shift work and risk of colorectal cancer in the nurses' health study |
| Q33755115 | Oral Mucositis: Melatonin Gel an Effective New Treatment |
| Q34072314 | Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin |
| Q36077513 | Pineal Gland Calcification in Kurdistan: A Cross-Sectional Study of 480 Roentgenograms |
| Q48218848 | Pineal melatonin level disruption in humans due to electromagnetic fields and ICNIRP limits |
| Q38803216 | Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder |
| Q34285562 | Potential role of melatonin in prevention and treatment of oral carcinoma |
| Q44604283 | Protective effect of melatonin against fractionated irradiation‐induced epiphyseal injury in a weanling rat model |
| Q41791273 | Protective effect of melatonin against mitomycin C-induced genotoxic damage in peripheral blood of rats. |
| Q36282835 | Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal |
| Q53763182 | Quantitative structure-activity relationships studies of antioxidant hexahydropyridoindoles and flavonoid derivatives. |
| Q28387506 | Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure |
| Q41992349 | Radioprotective potential of melatonin against ⁶⁰Co γ-ray-induced testicular injury in male C57BL/6 mice |
| Q88793049 | Restoration of hydroxyindole O-methyltransferase levels in human cancer cells induces a tryptophan-metabolic switch and attenuates cancer progression |
| Q34949853 | Rotating night shift work and risk of ovarian cancer. |
| Q34764890 | Rotating night shifts and risk of skin cancer in the nurses' health study |
| Q37268633 | Rotating night-shift work and lung cancer risk among female nurses in the United States |
| Q48237910 | Sleep disturbance after pinealectomy in patients with pineocytoma WHO°I. |
| Q38965221 | Sleep duration and breast cancer prognosis: perspectives from the Women's Healthy Eating and Living Study |
| Q35545847 | Sleep duration and risk of lung cancer in the physicians' health study |
| Q37439889 | Sleep, immunity and inflammation in gastrointestinal disorders |
| Q46861710 | Supplementation of IVF medium with melatonin: effect on sperm functionality and in vitro produced bovine embryos |
| Q41982914 | The disaster in Japan: utility of melatonin in providing protection against ionizing radiation |
| Q35753913 | The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial |
| Q33399301 | The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials |
| Q42177224 | The molecular biology of soft-tissue sarcomas and current trends in therapy |
| Q36453337 | The role of melatonin in immuno-enhancement: potential application in cancer |
| Q36671329 | Therapeutic applications of melatonin |
| Q36872043 | Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment. |
| Q37210222 | Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks. |
| Q33722863 | Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. |
| Q37071422 | Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women |
| Q46915150 | Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels |
| Q23921999 | Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II |
| Q46609311 | Urinary melatonin levels and breast cancer risk |
| Q34564079 | Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort |
| Q23910078 | Validation of a light questionnaire with real-life photopic illuminance measurements: the Harvard Light Exposure Assessment questionnaire |
| Q33597963 | What is known about melatonin, chemotherapy and altered gene expression in breast cancer |
Search more.